CBD May Reduce Orofacial Pain, Study Suggests

A 2026 mouse study found that cannabidiol (CBD) reduced several pain-related responses and altered inflammatory and brain-signaling measures. The results support further research, but they do not establish CBD as a treatment for a person’s toothache, jaw disorder, depression or anxiety.

What the Mouse Study Found

Wuyue Wang and colleagues published their study in Brain Research Bulletin. They used formalin injected into mice’s upper lips to model acute orofacial inflammatory pain. A separate chronic-pain model used complete Freund’s adjuvant injected into the paw, not the face.

Local CBD reduced the later inflammatory phase of the formalin response. Researchers reported changes in inflammatory markers and endocannabinoid signaling, with peripheral effects linked mainly to CB2 and central effects to CB1 signaling. In the chronic model, systemic CBD reduced mechanical sensitivity and anxiety- and depression-like behaviors and improved a cognitive test measure. Serotonin activity in the central amygdala also changed.

These are experimental animal outcomes. Behavioral tests in mice are not diagnoses or measures of recovery from human depression. Nor does a locally administered experimental preparation show that rubbing a retail CBD oil on the gums will work.

Mechanisms Are Not Yet a Clinical Treatment Plan

The endocannabinoid system provides possible targets for pain research. Measuring a change in a receptor-related pathway, inflammatory molecule or brain signal helps researchers develop hypotheses. It does not identify an effective, safe dose for a patient.

The next clinical questions are practical: Which diagnosis might respond? Which preparation and route are appropriate? How much benefit persists, and what adverse effects occur? A treatment also needs comparison with usual care, not simply a favorable laboratory result.

Readers exploring cannabis and inflammation or CBD and mental health should keep those outcomes separate. A proposed mechanism does not establish simultaneous relief of pain, anxiety, depression and cognitive problems.

Human Dental-Pain Research Is Preliminary and Mixed

A randomized trial published in 2024 enrolled 61 people with moderate-to-severe toothache. Single oral CBD doses of 10 or 20 mg/kg reduced pain compared with placebo during three hours of observation. Sedation, diarrhea and abdominal pain were more associated with CBD. The study did not compare CBD directly with standard pain medicines or establish long-term safety. Its weight-based research doses should not be copied at home.

A separate randomized trial of CBD-rich extract before root-canal treatment found no significant advantage over placebo for reductions in dental anxiety or postoperative pain at the measured time points. Different preparations and situations may produce different results; one positive trial does not establish benefit across all orofacial conditions.

Neither trial demonstrates that CBD resolves the underlying cause of a toothache or confirms the mouse study’s proposed mood-related mechanisms in patients.

Toothache and Jaw Pain Need the Right Diagnosis

Orofacial pain covers different problems. The National Institute of Dental and Craniofacial Research explains that temporomandibular disorders (TMDs) involve jaw joints, chewing muscles or related problems. “TMJ” names the joint itself. Mouth or facial pain can have other causes, so a dentist or clinician may need to rule those out.

For many TMDs, conservative approaches come first: temporary dietary changes, appropriate exercises, reducing clenching and other habits, and clinician-directed pain management. Physical therapy and behavioral approaches may also help. Persistent symptoms do not automatically justify irreversible changes to the bite or surgery.

For acute dental pain after extractions or temporary toothache management, ADA guidance identifies nonopioid medicines, including NSAIDs alone or with acetaminophen, as first-line options when appropriate for the patient. Medication can support care while the dental cause is addressed; it does not replace needed treatment.

A suspected dental abscess needs urgent dental attention. Difficulty breathing or swallowing, or substantial mouth swelling, requires emergency medical care. Do not delay assessment while experimenting with CBD.

CBD Safety Still Matters

FDA warns that CBD can cause liver injury and interact with other medicines. Review its use with a dentist, clinician or pharmacist, particularly before procedures or when taking other pain medicines. Tell the care team the product, amount and timing, and do not stop prescribed treatment without advice.

Do not put products intended only for external use inside the mouth. Retail products should not be assumed equivalent to a clinical-trial formulation. Our CBD Masterclass provides further background on interpreting cannabinoid claims.

The mouse findings are a reason to investigate CBD further. For someone in pain today, diagnosis, appropriate dental treatment and a reviewed pain-management plan remain the actionable priorities.